Langslet, Gisle
Oslo University Hospital
3 papers on CoChatORCID 0000-0003-4034-2243
Most cited papers
- Verified
Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
Robinson, J. G., Farnier, M., Krempf, M., Bergeron, J., Luc, G., Averna, M., Stroes, E. S., Langslet, G., Raal, F. J., El Shahawy, M., et al. (2015) · New England Journal of Medicine
Lipoproteins and Cardiovascular HealthLipid metabolism and disorders
Cited by 2,296
- Verified
PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial
Raal, F. J., Stein, E. A., Dufour, R., Turner, T., Civeira, F., Burgess, L., Langslet, G., Scott, R., Olsson, A. G., Sullivan, D., et al. (2015) · The Lancet
Lipoproteins and Cardiovascular HealthLipid metabolism and disorders
Cited by 756
- Verified
No effect of combined coenzyme Q10 and selenium supplementation on atorvastatin-induced myopathy
Bogsrud, M. P., Langslet, G., Ose, L., Arnesen, K.-E., Sm stuen, M. C., Malt, U. F., Woldseth, B., & Retterstøl, K. (2013) · Scandinavian Cardiovascular Journal
Coenzyme Q10 studies and effectsLipoproteins and Cardiovascular Health
Cited by 53
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free